RHP
AMGN icon

Royal Harbor Partners’s Amgen AMGN Stock Holding History

Royal Harbor Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,134
Closed -$2.4M – 77
2022
Q4 		$2.4M Sell
9,134
-719
-7% -$193K 1.48% 22
2022
Q3 		$2.22M Sell
9,853
-91
-0.9% -$22.1K 1.52% 20
2022
Q2 		$2.42M Buy
+9,944
New +$2.44M 1.65% 20

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Harbor Partners's AMGN Position: Q1 2023 in Review

Royal Harbor Partners sold out of Amgen (AMGN) in Q1 2023, closing a stake of 9,134 shares — an estimated $2.4M sold.

Royal Harbor Partners first reported a position in AMGN in Q2 2022 and held it in 3 quarters. The position peaked at $2.42M in Q2 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Royal Harbor Partners reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Royal Harbor Partners sold 9,134 Amgen shares in Q1 2023, an estimated $2.4M.
  • Royal Harbor Partners first reported a position in Amgen in Q2 2022 and held it in 3 quarters.
  • Royal Harbor Partners's Amgen position peaked at $2.42M in Q2 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Royal Harbor Partners's 13F filing for Q1 2023, filed 24 Apr 2023.